REDUCE-IT® Heart Failure Analyses by VASCEPA® (Icosapent Ethyl)-Driven Serum Eicosapentaenoic Acid (EPA) Levels Suggest Potential Benefit in New Heart Failure in Studied At-Risk Patients as Presented at the American College of Cardiology’s 70th Annual …

… by Deepak L. Bhatt, M.D., M.P.H., Brigham and … Dr. Deepak L. Bhatt, M.D., M.P.H., Executive Director of … company may enter into, such as mergers, acquisitions, dispositions, joint ventures or [...]

REDUCE-IT® Heart Failure Analyses by VASCEPA® (Icosapent Ethyl)-Driven Serum Eicosapentaenoic Acid (EPA) Levels Suggest Potential Benefit in New Heart Failure in Studied At-Risk Patients as Presented at the American College of Cardiology’s 70th Annual …

… by Deepak L. Bhatt, M.D., M.P.H., Brigham and … Dr. Deepak L. Bhatt, M.D., M.P.H., Executive Director of … company may enter into, such as mergers, acquisitions, dispositions, joint ventures or [...]